Literature DB >> 20613521

Structure and function of major histocompatibility complex class I antigens.

Xian C Li1, Malini Raghavan.   

Abstract

PURPOSE OF REVIEW: Major histocompatibility complex (MHC) class I molecules control the repertoire and function of CD8 T cells and NK cells, and both cell types are involved in transplant rejection. Understanding the regulatory role of MHC class I molecules is important in the design of better therapies. This review article focuses on molecular aspects of alloreactive recognition of MHC class I molecules by CD8 T cells and NK cells and on the functional activities of CD8 T cells and NK cells in transplant rejection and tolerance. RECENT
FINDINGS: Recent T cell receptor (TCR)-peptide-MHC class I crystal structures and structural and functional analyses of MHC class I interactions with NK cell inhibitory receptors have revealed new insights into molecular aspects of allorecognition of MHC class I molecules by CD8 T cells and NK cells. In functional studies, CD8 T cells and NK cells have been shown to have conditional and model-dependent roles in allograft rejection. NK cells have also been shown to have an unexpected role in tolerance induction in the transplantation setting.
SUMMARY: Both CD8 and NK cells play diverse roles in graft rejection and tolerance induction. Further understanding of molecular interactions between MHC class I molecules and TCRs or NK receptors is important and highly relevant to transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20613521      PMCID: PMC3711407          DOI: 10.1097/MOT.0b013e32833bfb33

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  45 in total

1.  Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.

Authors:  Geraldine M O'Connor; Kieran J Guinan; Rodat T Cunningham; Derek Middleton; Peter Parham; Clair M Gardiner
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 2.  Frontiers in nephrology: T cell memory as a barrier to transplant tolerance.

Authors:  Anna Valujskikh; Xian Chang Li
Journal:  J Am Soc Nephrol       Date:  2007-07-18       Impact factor: 10.121

3.  Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

Authors:  Achim K Moesta; Paul J Norman; Makoto Yawata; Nobuyo Yawata; Michael Gleimer; Peter Parham
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

4.  Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice.

Authors:  K Minamimura; K Sato; H Yagita; T Tanaka; S Arii; T Maki
Journal:  Am J Transplant       Date:  2008-02-05       Impact factor: 8.086

Review 5.  Cellular mechanisms underlying acute graft rejection: time for reassessment.

Authors:  Maria-Luisa Alegre; Sandrine Florquin; Michel Goldman
Journal:  Curr Opin Immunol       Date:  2007-08-27       Impact factor: 7.486

Review 6.  The innate natural killer cells in transplant rejection and tolerance induction.

Authors:  Alexander Kroemer; Karoline Edtinger; Xian C Li
Journal:  Curr Opin Organ Transplant       Date:  2008-08       Impact factor: 2.640

Review 7.  Functions of natural killer cells.

Authors:  Eric Vivier; Elena Tomasello; Myriam Baratin; Thierry Walzer; Sophie Ugolini
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

8.  The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.

Authors:  Bree A Foley; Dianne De Santis; Els Van Beelen; Louise J Lathbury; Frank T Christiansen; Campbell S Witt
Journal:  Blood       Date:  2008-04-02       Impact factor: 22.113

Review 9.  MHC class I assembly: out and about.

Authors:  Malini Raghavan; Natasha Del Cid; Syed Monem Rizvi; Larry Robert Peters
Journal:  Trends Immunol       Date:  2008-09       Impact factor: 16.687

Review 10.  Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia.

Authors:  Andrea Velardi; Loredana Ruggeri; Antonella Mancusi; Franco Aversa; Frank T Christiansen
Journal:  Curr Opin Immunol       Date:  2009-08-28       Impact factor: 7.486

View more
  11 in total

Review 1.  Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly.

Authors:  Ivan K Chinn; M Louise Markert
Journal:  J Allergy Clin Immunol       Date:  2011-04-21       Impact factor: 10.793

Review 2.  Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance.

Authors:  Chong Jai Kim; Roberto Romero; Piya Chaemsaithong; Jung-Sun Kim
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

3.  The Full Model of the pMHC-TCR-CD3 Complex: A Structural and Dynamical Characterization of Bound and Unbound States.

Authors:  Josephine Alba; Marco D'Abramo
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

Review 4.  Calreticulin in the immune system: ins and outs.

Authors:  Malini Raghavan; Sanjeeva J Wijeyesakere; Larry Robert Peters; Natasha Del Cid
Journal:  Trends Immunol       Date:  2012-09-07       Impact factor: 16.687

5.  Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes.

Authors:  Elisa Nurzia; Daniele Narzi; Alberto Cauli; Alessandro Mathieu; Valentina Tedeschi; Silvana Caristi; Rosa Sorrentino; Rainer A Böckmann; Maria Teresa Fiorillo
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 6.  Regulation of the antigen presentation machinery in cancer and its implication for immune surveillance.

Authors:  Adithya Balasubramanian; Thomas John; Marie-Liesse Asselin-Labat
Journal:  Biochem Soc Trans       Date:  2022-04-29       Impact factor: 4.919

7.  Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2.

Authors:  Jeffrey T Galligan; Gustavo Martinez-Noël; Verena Arndt; Sebastian Hayes; Thomas W Chittenden; J Wade Harper; Peter M Howley
Journal:  J Proteome Res       Date:  2014-12-15       Impact factor: 4.466

Review 8.  Endoplasmic reticulum chaperones and oxidoreductases: critical regulators of tumor cell survival and immunorecognition.

Authors:  Tomás Gutiérrez; Thomas Simmen
Journal:  Front Oncol       Date:  2014-10-27       Impact factor: 6.244

9.  Human rhinovirus-specific CD8 T cell responses target conserved and unusual epitopes.

Authors:  Marta Gomez-Perosanz; Jose L Sanchez-Trincado; Miguel Fernandez-Arquero; John Sidney; Alessandro Sette; Esther M Lafuente; Pedro A Reche
Journal:  FASEB J       Date:  2020-11-23       Impact factor: 5.191

Review 10.  Exosomes and Immune Response in Cancer: Friends or Foes?

Authors:  Francisco M Barros; Fatima Carneiro; Jose C Machado; Sónia A Melo
Journal:  Front Immunol       Date:  2018-04-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.